{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:22:00Z","timestamp":1791570120022,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008374","name":"Center for AIDS Research, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1-R01-AI-132833"],"award-info":[{"award-number":["1-R01-AI-132833"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bmc.2020.115952","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T22:53:44Z","timestamp":1608159224000},"page":"115952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents"],"prefix":"10.1016","volume":"31","author":[{"given":"Franck","family":"Amblard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Boucle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Bassit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Ollinger-Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Schinazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115952_b0005","unstructured":"World Health Organization (WHO) website, available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 02 June 2020."},{"key":"10.1016\/j.bmc.2020.115952_b0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2019.02.009","article-title":"Recent advances in the development of HBV capsid assembly modulators","volume":"50","author":"Nijampatnam","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2020.115952_b0015","doi-asserted-by":"crossref","first-page":"e02439","DOI":"10.1128\/AAC.02439-19","article-title":"Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379 Antimicrob","volume":"64","author":"Berke","year":"2020","journal-title":"Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115952_b0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2468-1253(19)30346-2","article-title":"Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial","volume":"5","author":"Yuen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bmc.2020.115952_b0025","unstructured":"Yuen MF, Agarwal K, Gane EJ, et al. The second-generation hepatitis B virus (HBV) core inhibitor (CI) ABI-H2158 is associated with potent antiviral activity in a 14-Day monotherapy study in HBeAg-positive patients with chronic hepatitis B (CHB) AASLD 2019 Nov 8-12 Boston."},{"key":"10.1016\/j.bmc.2020.115952_b0030","unstructured":"https:\/\/www.hepb.org\/treatment-and-management\/drug-watch\/."},{"key":"10.1016\/j.bmc.2020.115952_b0035","first-page":"e01701","article-title":"Novel hepatitis B virus capsid assembly modulator induces potent antiviral responses in vitro and humanized mice","volume":"64","author":"Amblard","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115952_b0040","article-title":"Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector","volume":"407\u2013421","author":"Sari","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115952_b0045","article-title":"Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2020.115952_b0050","unstructured":"BIOvIA DS. Discovery studio modeling environment. San Diego, Dassault Systemes, Release, vol. 4; 2015."},{"key":"10.1016\/j.bmc.2020.115952_b0055","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/AAC.46.12.3854-3860.2002","article-title":"Antiviral activities and cellular toxicities of modified 2\u2032,3\u2032-dideoxy-2\u2032,3\u2032-didehydrocytidine analogues","volume":"46","author":"Stuyver","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115952_b0060","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.01091-13","article-title":"Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115952_b0065","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115952_b0070","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1128\/JCM.38.8.2897-2901.2000","article-title":"Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays","volume":"38","author":"Pas","year":"2000","journal-title":"J Clin Microbiol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:17:52Z","timestamp":1778566672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620307823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":14,"alternative-id":["S0968089620307823"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115952","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115952"}}